Aditya Juloori
@ajuloorimd
Radiation Oncologist @UChicagoMed, Thoracic, Head/Neck
ID: 780064454247649280
25-09-2016 15:20:33
495 Tweet
1,1K Followers
992 Following
Rationale for Investigation of Neoadjuvant Chemoimmunotherapy Prior to Chemoradiation in Unresectable Stage III Non-Small Cell Lung Cancer: brnw.ch/21wRHpX Authored by Aditya Juloori et al. #NSCLC #lcsm
Just when you thought the horizon for locally advanced NSCLC couldn’t get brighter… along comes HORIZON-01: ChemoRadiotherapy followed by Alectinib, Entrectinib, or Pralsetinib. Thanks Millie Das MD for the heads up. #ATS2025 #RadOncMeetsTargetedTherapy
Excited to share our new commentary in Journal of Clinical Oncology (my first one) ASCO 🚨 In this patient-centered piece, we discuss the emerging case for organ preservation in select patients with locally advanced esophageal/GEJ cancer achieving a complete clinical response (cCR). Inspired by